CAMECO CORP (CCJ)

CA13321L1085 - Common Stock

52.49  +0.05 (+0.1%)

Fundamental Rating

4

Taking everything into account, CCJ scores 4 out of 10 in our fundamental rating. CCJ was compared to 205 industry peers in the Oil, Gas & Consumable Fuels industry. CCJ scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CCJ is valied quite expensively at the moment, while it does show a decent growth rate.



3

1. Profitability

1.1 Basic Checks

In the past year CCJ was profitable.
CCJ had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CCJ reported negative net income in multiple years.
CCJ had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

CCJ has a worse Return On Assets (1.25%) than 72.06% of its industry peers.
CCJ's Return On Equity of 1.88% is on the low side compared to the rest of the industry. CCJ is outperformed by 72.06% of its industry peers.
CCJ has a Return On Invested Capital of 2.95%. This is in the lower half of the industry: CCJ underperforms 72.55% of its industry peers.
Industry RankSector Rank
ROA 1.25%
ROE 1.88%
ROIC 2.95%
ROA(3y)1.1%
ROA(5y)0.72%
ROE(3y)1.78%
ROE(5y)1.15%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin of CCJ (4.17%) is worse than 66.18% of its industry peers.
CCJ's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 12.49%, CCJ is doing worse than 62.75% of the companies in the same industry.
In the last couple of years the Operating Margin of CCJ has grown nicely.
CCJ's Gross Margin of 23.81% is on the low side compared to the rest of the industry. CCJ is outperformed by 65.69% of its industry peers.
In the last couple of years the Gross Margin of CCJ has grown nicely.
Industry RankSector Rank
OM 12.49%
PM (TTM) 4.17%
GM 23.81%
OM growth 3YN/A
OM growth 5Y26.02%
PM growth 3YN/A
PM growth 5Y11.89%
GM growth 3Y54.28%
GM growth 5Y8.95%

6

2. Health

2.1 Basic Checks

CCJ has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CCJ has more shares outstanding
CCJ has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CCJ has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 7.41 indicates that CCJ is not in any danger for bankruptcy at the moment.
CCJ's Altman-Z score of 7.41 is amongst the best of the industry. CCJ outperforms 93.63% of its industry peers.
CCJ has a debt to FCF ratio of 3.27. This is a good value and a sign of high solvency as CCJ would need 3.27 years to pay back of all of its debts.
CCJ has a better Debt to FCF ratio (3.27) than 68.63% of its industry peers.
A Debt/Equity ratio of 0.20 indicates that CCJ is not too dependend on debt financing.
The Debt to Equity ratio of CCJ (0.20) is better than 67.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 3.27
Altman-Z 7.41
ROIC/WACC0.38
WACC7.68%

2.3 Liquidity

A Current Ratio of 2.88 indicates that CCJ has no problem at all paying its short term obligations.
CCJ has a better Current ratio (2.88) than 81.37% of its industry peers.
CCJ has a Quick Ratio of 1.26. This is a normal value and indicates that CCJ is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.26, CCJ is doing good in the industry, outperforming 64.22% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.88
Quick Ratio 1.26

6

3. Growth

3.1 Past

CCJ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -29.85%.
CCJ shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.91% yearly.
CCJ shows a strong growth in Revenue. In the last year, the Revenue has grown by 23.31%.
The Revenue has been growing slightly by 4.35% on average over the past years.
EPS 1Y (TTM)-29.85%
EPS 3YN/A
EPS 5Y7.91%
EPS Q2Q%-103.12%
Revenue 1Y (TTM)23.31%
Revenue growth 3Y12.86%
Revenue growth 5Y4.35%
Sales Q2Q%25.32%

3.2 Future

The Earnings Per Share is expected to grow by 31.81% on average over the next years. This is a very strong growth
CCJ is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.57% yearly.
EPS Next Y-25.04%
EPS Next 2Y42.5%
EPS Next 3Y38.67%
EPS Next 5Y31.81%
Revenue Next Year18.69%
Revenue Next 2Y13.64%
Revenue Next 3Y10.71%
Revenue Next 5Y8.57%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 159.06, CCJ can be considered very expensive at the moment.
76.47% of the companies in the same industry are cheaper than CCJ, based on the Price/Earnings ratio.
CCJ is valuated expensively when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 47.07 indicates a quite expensive valuation of CCJ.
Based on the Price/Forward Earnings ratio, CCJ is valued a bit more expensive than 72.06% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.73. CCJ is valued rather expensively when compared to this.
Industry RankSector Rank
PE 159.06
Fwd PE 47.07

4.2 Price Multiples

80.39% of the companies in the same industry are cheaper than CCJ, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CCJ indicates a slightly more expensive valuation: CCJ is more expensive than 62.75% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 85.14
EV/EBITDA 59.31

4.3 Compensation for Growth

CCJ's earnings are expected to grow with 38.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)20.12
EPS Next 2Y42.5%
EPS Next 3Y38.67%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.21%, CCJ is not a good candidate for dividend investing.
CCJ's Dividend Yield is slightly below the industry average, which is at 7.14.
With a Dividend Yield of 0.21, CCJ pays less dividend than the S&P500 average, which is at 2.36.
Industry RankSector Rank
Dividend Yield 0.21%

5.2 History

The dividend of CCJ decreases each year by -7.75%.
CCJ has been paying a dividend for at least 10 years, so it has a reliable track record.
CCJ has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)-7.75%
Div Incr Years1
Div Non Decr Years6

5.3 Sustainability

44.71% of the earnings are spent on dividend by CCJ. This is a bit on the high side, but may be sustainable.
DP44.71%
EPS Next 2Y42.5%
EPS Next 3Y38.67%

CAMECO CORP

NYSE:CCJ (12/23/2024, 9:37:26 AM)

52.49

+0.05 (+0.1%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)02-20 2025-02-20/amc
Inst Owners76.29%
Inst Owner Change-2.42%
Ins Owners0.42%
Ins Owner ChangeN/A
Market Cap22.85B
Analysts82.67
Price Target83.03 (58.18%)
Short Float %4.26%
Short Ratio4.1
Dividend
Industry RankSector Rank
Dividend Yield 0.21%
Dividend Growth(5Y)-7.75%
DP44.71%
Div Incr Years1
Div Non Decr Years6
Ex-Date11-27 2024-11-27 (0.16)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-75.2%
Min EPS beat(2)-103.96%
Max EPS beat(2)-46.43%
EPS beat(4)0
Avg EPS beat(4)-52.63%
Min EPS beat(4)-103.96%
Max EPS beat(4)-5.49%
EPS beat(8)3
Avg EPS beat(8)-10.58%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.28%
Min Revenue beat(2)-22.8%
Max Revenue beat(2)-3.76%
Revenue beat(4)1
Avg Revenue beat(4)-11.5%
Min Revenue beat(4)-22.8%
Max Revenue beat(4)2.54%
Revenue beat(8)3
Avg Revenue beat(8)-6.5%
Revenue beat(12)5
Avg Revenue beat(12)-3.36%
Revenue beat(16)6
Avg Revenue beat(16)-2.42%
PT rev (1m)6.43%
PT rev (3m)10.9%
EPS NQ rev (1m)-6.07%
EPS NQ rev (3m)-21.04%
EPS NY rev (1m)-30.77%
EPS NY rev (3m)-33.75%
Revenue NQ rev (1m)3.68%
Revenue NQ rev (3m)19.32%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-1.43%
Valuation
Industry RankSector Rank
PE 159.06
Fwd PE 47.07
P/S 11.75
P/FCF 85.14
P/OCF 56.97
P/B 5.29
P/tB 5.33
EV/EBITDA 59.31
EPS(TTM)0.33
EY0.63%
EPS(NY)1.12
Fwd EY2.12%
FCF(TTM)0.62
FCFY1.17%
OCF(TTM)0.92
OCFY1.76%
SpS4.47
BVpS9.92
TBVpS9.85
PEG (NY)N/A
PEG (5Y)20.12
Profitability
Industry RankSector Rank
ROA 1.25%
ROE 1.88%
ROCE 3.99%
ROIC 2.95%
ROICexc 3.02%
ROICexgc 3.04%
OM 12.49%
PM (TTM) 4.17%
GM 23.81%
FCFM 13.8%
ROA(3y)1.1%
ROA(5y)0.72%
ROE(3y)1.78%
ROE(5y)1.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y23.63%
ROICexc growth 3YN/A
ROICexc growth 5Y23.76%
OM growth 3YN/A
OM growth 5Y26.02%
PM growth 3YN/A
PM growth 5Y11.89%
GM growth 3Y54.28%
GM growth 5Y8.95%
F-Score5
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 3.27
Debt/EBITDA 2.21
Cap/Depr 85.85%
Cap/Sales 6.82%
Interest Coverage 4.25
Cash Conversion 100.93%
Profit Quality 331.39%
Current Ratio 2.88
Quick Ratio 1.26
Altman-Z 7.41
F-Score5
WACC7.68%
ROIC/WACC0.38
Cap/Depr(3y)67.49%
Cap/Depr(5y)53.38%
Cap/Sales(3y)6.77%
Cap/Sales(5y)5.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.85%
EPS 3YN/A
EPS 5Y7.91%
EPS Q2Q%-103.12%
EPS Next Y-25.04%
EPS Next 2Y42.5%
EPS Next 3Y38.67%
EPS Next 5Y31.81%
Revenue 1Y (TTM)23.31%
Revenue growth 3Y12.86%
Revenue growth 5Y4.35%
Sales Q2Q%25.32%
Revenue Next Year18.69%
Revenue Next 2Y13.64%
Revenue Next 3Y10.71%
Revenue Next 5Y8.57%
EBIT growth 1Y67.54%
EBIT growth 3YN/A
EBIT growth 5Y31.5%
EBIT Next Year298.02%
EBIT Next 3Y81.22%
EBIT Next 5Y49.4%
FCF growth 1Y177.09%
FCF growth 3YN/A
FCF growth 5Y-2.67%
OCF growth 1Y101.64%
OCF growth 3Y129.54%
OCF growth 5Y0.61%